OncLive: HERTHENA-Breast04 Is Set to Delineate the Role of HER3-Targeted Therapy in Advanced HR+ Breast Cancer
June 4, 2026
OncLive: HERTHENA-Breast04 Is Set to Delineate the Role of HER3-Targeted Therapy in Advanced HR+ Breast Cancer
MedPage Today: Accumulating Evidence Lifts GLP-1s to Clinical Trial for Breast Cancer Prevention
June 4, 2026
MedPage Today: Accumulating Evidence Lifts GLP-1s to Clinical Trial for Breast Cancer Prevention
Becker’s Dental + DSO Review: DSOs, dental schools and companies secure $270M in funding boons
June 4, 2026
Becker’s Dental + DSO Review: DSOs, dental schools and companies secure $270M in funding boons
Healio: HemOnc Today announces 2026 Disruptive Innovators
June 4, 2026
Healio: HemOnc Today announces 2026 Disruptive Innovators
The New York Times: Raising Dementia Awareness, One Black Church at a Time
June 4, 2026
The New York Times: Raising Dementia Awareness, One Black Church at a Time
San Antonio Business Journal: UT San Antonio lands millions in new state funding
June 4, 2026
San Antonio Report: UT San Antonio lands millions in new state funding
Rebellion Research: 10 Cheapest Dental Schools in America for 2026 Ranked by Value and Tuition
June 3, 2026
Rebellion Research: 10 Cheapest Dental Schools in America for 2026 Ranked by Value and Tuition
The Washington Post: The science around GLP-1 drugs and cancer is suddenly getting a lot more interesting
June 3, 2026
The Washington Post: The science around GLP-1 drugs and cancer is suddenly getting a lot more interesting
Reuters: GLP-1 drugs may have a beneficial effect across many types of cancer
June 3, 2026
Colton Jones, MD, hematology and oncology fellow at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), was quoted in this article. Read More (subscription required)
Scientific American: Hyperbaric oxygen therapy is being explored as a long COVID treatment. Here’s what the research shows
June 2, 2026
Scientific American: Hyperbaric oxygen therapy is being explored as a long COVID treatment. Here’s what the research shows